Lantern Pharma CEO Panna Sharma Discusses Progress in AI-Driven Cancer Drug Development

Small Stocks, Big Money ›

14:18 | Oct 7th

Lantern Pharma Inc. (Nasdaq: LTRN) is a clinical-stage biopharmaceutical company redefiningoncology drug development through artificial intelligence. Its proprietary RADR® platform leveragesover 200 b...Show More